Molecular Mechanism and Potential Targets for Blocking HPV-Induced Lesion Development
Author(s) -
Eduardo Guzmán-Olea,
Víctor H. Bermúdez-Morales,
Oscar PeraltaZaragoza,
Kirvis Torres-Poveda,
Vicente MadridMarina
Publication year - 2011
Publication title -
journal of oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.228
H-Index - 54
eISSN - 1687-8469
pISSN - 1687-8450
DOI - 10.1155/2012/278312
Subject(s) - immune system , medicine , mechanism (biology) , disease , cervical cancer , lesion , immunology , cancer , epidemiology , human papillomavirus , immune status , hpv infection , pathology , philosophy , epistemology
Persistent infection with high-risk HPV is the etiologic agent associated with the development of cervical cancer (CC) development. However, environmental, social, epidemiological, genetic, and host factors may have a joint influence on the risk of disease progression. Cervical lesions caused by HPV infection can be removed naturally by the host immune response and only a small percentage may progress to cancer; thus, the immune response is essential for the control of precursor lesions and CC. We present a review of recent research on the molecular mechanisms that allow HPV-infected cells to evade immune surveillance and potential targets of molecular therapy to inhibit tumor immune escape.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom